MicroVision (MVIS) general counsel acquires 9,395 shares in exempt purchase

Rhea-AI Filing Summary

MicroVision, Inc. general counsel Drew G. Markham acquired 9,395 shares of common stock directly from the company on March 15, 2026. The purchase price was $0.5322 per share, matching the closing price on March 13, 2026 as set by a subscription agreement.

Following this transaction, Markham directly holds 388,329 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which generally covers certain insider transactions approved under specific governance procedures.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Markham Drew G

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	03/15/2026		A(2)		9,395	A	$0.5322	388,329	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to a Subscription Agreement executed on March 15, 2026 between MicroVision, Inc. ("MicroVision") and the reporting person, the reporting person acquired 9,395 shares of MicroVision's common stock directly from MicroVision at a purchase price of $0.5322 per share, the closing price of MicroVision's common stock on March 13, 2026.

2. The purchase is intended to be an exempt transaction pursuant to Rule 16b-3.

	/s/ Drew G. Markham	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MicroVision (MVIS) report for Drew G. Markham?

MicroVision reported that general counsel Drew G. Markham acquired 9,395 shares of common stock. The shares were purchased directly from the company under a subscription agreement at $0.5322 per share, matching the March 13, 2026 closing price.

At what price did MicroVision (MVIS) insider Drew G. Markham acquire shares?

Drew G. Markham acquired MicroVision common stock at $0.5322 per share. This price matched the closing market price on March 13, 2026 and was specified in a subscription agreement with the company for the 9,395-share purchase.

How many MicroVision (MVIS) shares does Drew G. Markham hold after this Form 4?

After the reported transaction, Drew G. Markham directly holds 388,329 shares of MicroVision common stock. This reflects the addition of 9,395 shares acquired from the company on March 15, 2026 via a subscription agreement at $0.5322 per share.

Was the MicroVision (MVIS) insider share purchase intended to be exempt under Rule 16b-3?

Yes. The filing states the purchase is intended to be an exempt transaction under Rule 16b-3. That rule generally provides exemptions for certain insider transactions that meet specific governance and approval conditions set out in securities regulations.

Did MicroVision (MVIS) general counsel buy shares on the open market or from the company?

MicroVision’s general counsel acquired the shares directly from the company, not on the open market. A subscription agreement dated March 15, 2026 set the purchase of 9,395 common shares at the $0.5322 closing price from March 13, 2026.